Used primarily as an intermediate in pharmaceutical synthesis, especially in the development of kinase inhibitors for cancer treatment. Its boron-containing group enables participation in Suzuki-Miyaura cross-coupling reactions, allowing efficient formation of carbon-carbon bonds during the preparation of complex drug molecules. This compound is particularly valuable in medicinal chemistry for constructing indazole-based scaffolds, which are present in several bioactive molecules and investigational drugs targeting oncology and inflammatory diseases.